Opioids and Smoking Cessation
Smoking, Smoking Cessation, Smoking, Tobacco
About this trial
This is an interventional treatment trial for Smoking
Eligibility Criteria
Inclusion Criteria:
1. 18-65 years of age. 2. Daily smoker (≥ 10 cigarettes per day for at least one year), biochemically confirmed via Carbon Monoxide [CO] analysis at least 8 ppm.
3. Motivation to quit smoking (≥ 5 on a 0-10 scale) 4. Interested in making a serious quit attempt in the next month 5. Not have decreased number of cigarettes by more than half in the past 6 months 6. Own a smartphone (for EMA) 7. Report of current (past 30-day) opioid use (opioid misuse group) 8. Verification of opioid use by positive urine toxicology screen & Positive Aberrant Drug Behavior Index (opioid misuse group)
- PDUQ > 11, +POTQ, +urine toxicology screen
Exclusion Criteria:
1. Current use of psychotropic medication. 2. Current use of nicotine replacement therapy, Zyban, or Chantix (or intention to use).
3. Use of other tobacco products, including e-cigarettes. 4. Current treatment for opioid misuse, including methadone, buprenorphine, or naltrexone.
5. Current diagnosis of Opioid Use Disorder. 6. Pregnancy (by self-report) 7. Limited mental capacity or inability to provide informed consent 8. Current suicidality (by structured clinical interview) 9. Lifetime or current psychosis
Sites / Locations
- Anxiety and Health Research Laboratory
Arms of the Study
Arm 1
Experimental
NRT smoking Cessation Intervention
All participants will be provided with the Nicotine Patch as an intervention